Europe Infusion Pump Market

Europe Infusion Pump Market Size (2022 to 2027)

The size of the European infusion pump market is forecasted to be growing at a CAGR of 6.2% from 2022 to 2027.

The growing population suffering from chronic diseases and the increasing geriatric population across Europe are majorly boosting the growth of the infusion pump market in Europe. The infusion pump is a medical device that helps to deliver fluids such as nutrients and medications such as insulin or other hormones, antibiotics, drugs, and pain relievers. Some types of infusion pumps are patient-controlled analgesia, syringes, insulin pump, and elastomeric. Cardiovascular disease, diabetes, and cancer are the most common chronic diseases in many populations. As per a recent survey, nearly 61 million population are suffering from diabetes in Europe region. For diabetic people, healthcare providers use infusion pumps to keep steady glucose levels, delivering the drug to the patient without any error. Infusion pumps are also used for cancer patients who need continuous chemotherapy treatment to prevent cancer or abnormal cell growth in the body. For the chemotherapy process, a controlled number of drugs should be sent to the bloodstream, which can be done through infusion pumps.

The growing number of surgical procedures happening and an increasing number of intensive care units across Europe are further fuelling the infusion pump market growth in Europe. Owing to the increasingly critical situation during the surgeries, the healthcare provider prefers to use infusion pumps for the patient to inject a certain amount of drug to reduce any side effects and dehydration problems. Increasing use of home-based infusion pumps to take treatment also demands the market. Most of the older population and disabled people are using home infusion pumps by healthcare specialists for a fast cure of the disease.

The rising number of R&D activities to innovate and manufacture advanced infusion pumps is propelling the infusion pump market growth in Europe. Many key players are focusing on developing ambulatory infusion pumps, which will increase their demand during the forecast period. In addition, the developer has designed several applications or software that show the dosage levels of the medications during the procedures. Increasing research and development and increasing pharmaceutical support are other factors for market growth.

On the other hand, the high cost of infusion pumps is the primary factor that restrains the market growth during the forecast period. In addition, increases in medication errors, lack of wireless connectivity, strict regulatory requirements of new products, lack of proper infrastructure, and lack of skilled professionals hamper the market growth in this region.

This market research report on the Europe infusion pump market has been segmented and sub-segmented into the following categories.

 By Type:

• Accessories and Consumables
• Devices

By Product:

• Volumetric infusion pumps
• Insulin infusion pumps
• Enteral infusion pumps
• Ambulatory infusion pumps
• Syringe infusion pumps
• Patient-controlled analgesia (PCA) pumps
• Implantable infusion pumps

By Application:

• Chemotherapy/Oncology
• Diabetes
• Gastroenterology
• Analgesia/pain management
• Pediatrics/neonatology
• Hematology
• Other applications

By End-User:

• Hospitals
• Home care settings
• Ambulatory care settings
• Academic and research institutes

By Country:

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe

Europe held a substantial share of the worldwide market in 2022 and is estimated to grow at a promising CAGR during the forecast period owing to the rapid adoption of advanced technologies in the healthcare sector. In addition, increasing the adoption of infusion pumps by hospitals, nursing homes, care centers, and clinics also helps with the demand for market growth.

The UK market accounted for a notable share of the European market during the forecast period owing to the increasing development of smart infusion pumps in the country. As per the report by the National Patient Safety Agency in England, there is an increase in death or critical life situations due to injectable medicine. Several studies have also been conducted in United Kingdom hospitals to check the rate of infusion errors. To reduce this error, regional manufacturers focus on developing smart infusion devices to deliver drugs to patients. These smart infusion pumps include features such as a sensor, a battery system, and backup power.

Germany held a considerable share of the European market in 2022 and is expected to grow at a promising CAGR during the forecast period.

KEY MARKET PLAYERS:

Companies playing a prominent role in the European infusion pump market profiled in this report are BD, B. Braun Melsungen AG, Baxter., Fresenius Kabi AG, ICU Medical, Inc., Smiths Group PLC, Medtronic, Moog Inc., Terumo Corporation, Avanos Corporate., NIPRO, Insulet Corporation, Tandem Diabetes Care, Inc., JMS Co.Ltd. and F. Hoffmann-La Roche Ltd.